欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
PT/H/1743/001
药品名称
Nebivolol Aurobindo
活性成分
nebivolol hydrochloride 2.72 mg
剂型
Tablet
上市许可持有人
Aurobindo Pharma (Portugal), Unipessoal, Lda.
参考成员国 - 产品名称
Portugal (PT)
互认成员国 - 产品名称
Netherlands (NL)
Nebivolol Aurobindo 5 mg, tabletten
许可日期
2017/09/04
最近更新日期
2024/01/19
药物ATC编码
C07AB12 nebivolol
申请类型
TypeLevel1:
Abridged
TypeLevel2:
Initial Application
TypeLevel3:
Other Generic application Art 10.3 Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
PubAR
|
610782_610783_20170919_PAR_ACM
Date of last change:2024/09/06
Final Product Information
|
Labelling
Date of last change:2024/09/06
Final Product Information
|
PIL
Date of last change:2024/09/06
Final Product Information
|
SPC
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase